New Lund model aims to shorten the path to life-saving cell and gene therapies
Despite groundbreaking research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will shorten lead times and reduce costs – with the aim to give more patients access to advanced, potentially curative treatments.
In brief:
Why promising cell and gene therapies fail to reach implementation – and how a Swedish model aims to solve the problem
From discovery to reimbursement in healthcare: the ...